AtriCure (ATRC) Financials

$53.73

$2.21 (4.29%)

As on 08-Sep-2026 16:04EDT

Market cap

$2,621 Mln

Revenue (TTM)

$570 Mln

P/E Ratio

245.3

P/B Ratio

5.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	569.62	534.53	465.31	399.25	330.38	274.33
Cost of Revenue	135.77	136.79	117.78	98.88	84.44	68.47
Gross Profit	433.85	397.74	347.52	300.37	245.94	205.86
Operating Expenses	419.96	401.19	387.54	327.05	288.61	150.66
Operating Profit (EBIT)	13.89	-3.45	-40.01	-26.68	-42.67	55.21
Other Income	--	--	--	--	1.46	0.10
Profit before Tax	12.09	-10.16	-43.67	-29.85	-46.20	50.39
Provision for Tax	1.54	1.29	1.02	0.59	0.27	0.19
Profit after Tax (Net Income)	10.55	-11.45	-44.70	-30.44	-46.47	50.20
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-46.47	50.20

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	516.43	491.94	460.97	466.17	456.75	483.76
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	78.29	80.72	74.94	73.20	70.30	75.11
Current Liabilities	81.92	81.52	73.42	74.57	58.39	56.45
Total Liabilities	758.56	654.18	609.33	613.93	585.45	615.31

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	331.11	331.66	341.50	347.69	370.23	419.24
Current Assets	345.53	322.52	267.83	266.25	215.21	196.08
Total Assets	758.56	654.18	609.33	613.93	585.45	615.31
Total Debt*	71.05	88.02	76.53	74.49	74.55	75.65
Net Current Assets	263.62	241.00	194.40	191.68	156.82	139.63

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	57.33	12.20	4.48	-22.14	-13.78
Cash Flow from Investing Activities	--	-14.55	30.23	21.82	44.01	23.50
Cash from Financing Activities	--	1.18	-3.60	-0.03	-7.06	-7.64
Net Cash Inflow / Outflow	--	--	--	--	14.81	1.71

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.21	-0.23	-0.95	-0.66	-1.01	1.11
Cash EPS ($)	--	0.19	-0.55	-0.34	-0.76	1.34
Adjusted Book Value ($)	--	10.07	9.79	10.04	9.95	10.67
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.17	0.26	0.10	-0.48	-0.30
Free Cash Flow per Share ($)	--	0.99	-0.24	-0.81	-0.85	-0.52

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-2.05	-8.29	-5.68	-8.52	9.60
ROE (%)	2.09	-2.40	-9.64	-6.60	-9.88	11.20
ROA (%)	1.47	-1.81	-7.31	-5.08	-7.74	7.55
EBIT Margin (%)	2.96	-0.80	-8.01	-5.74	-12.92	20.16
Net Margin (%)	1.85	-2.14	-9.61	-7.62	-14.00	18.29
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	13.94	0.15	0.17	0.21	0.20	0.33
EBIT Growth (%)	157.70	88.50	-62.58	46.28	-177.15	225.03
Net Profit Growth (%)	129.02	74.39	-46.85	34.49	-192.56	204.24
EPS Growth (%)	127.92	0.75	-0.45	0.35	-1.91	2.01
Book Value Growth (%)	7.70	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	245.33	-168.89	-32.21	-54.46	-43.85	62.79
Price / Book Value	5.17	3.93	3.12	3.56	4.46	6.52
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	66.66	114.12	-75.18	-196.68	-64.31	47.28
Close Price ($)	27.98	39.56	30.56	35.69	44.38	69.53
High Price ($)	43.18	43.11	39.05	59.61	72.31	89.18
Low Price ($)	25.37	28.29	18.94	32.27	32.51	52.54
Market Cap ($ Cr)	2,620.63	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.12	0.18	0.17	0.16	0.16	0.16
Short term debt to equity ratio	--	0.01	0.01	0.01	0.01	0.00
Current Ratio	4.22	3.96	3.65	3.57	3.69	3.47
Quick Ratio	3.19	2.99	2.62	2.66	2.90	2.78
Interest Coverage	2.71	-0.73	-5.82	-3.31	-8.56	11.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	14.04	12.47	12.97	13.15	12.92	12.04
Asset Turnover	0.79	0.85	0.76	0.67	0.55	0.41
Receivable days	--	43.39	44.29	43.54	41.85	37.39
Inventory Days	--	205.37	222.08	210.24	183.61	197.35
Payable days	--	138.09	81.23	87.28	83.26	83.57
Cash Conversion Cycle	--	110.67	185.15	166.51	142.21	151.17

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.